Literature DB >> 6475962

Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.

G Monckton, M Zatz, C S Mion, H Marusyk.   

Abstract

We blind-tested a method that in earlier studies had shown increased leucine uptake in muscle fibers of biopsy specimens from three obligate carriers and seven of 11 putative carriers of the gene for Duchenne muscular dystrophy. Here, muscle samples obtained at biopsy in seven obligate carriers and nine control subjects from Brazil were examined in Canada without knowledge of the carrier status or serum enzyme concentrations. Leucine uptake was increased in four controls and within normal range in four carriers, a rate of false-positives and -negatives that underscores the need for blind-testing methods for detecting carriers of this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475962      PMCID: PMC1684495     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  A new approach for carrier detection in Duchenne muscular dystrophy. Protein synthesis of muscle polyribosomes in vitro.

Authors:  V Ionasescu; H Zellweger; T W Conway
Journal:  Neurology       Date:  1971-07       Impact factor: 9.910

2.  Carrier detection in X-linked Duchenne type muscular dystrophy. A pluridimensional investigation.

Authors:  H Radu; S Migea; Z Török; L Bordeianu; A Radu
Journal:  J Neurol Sci       Date:  1968 Mar-Apr       Impact factor: 3.181

3.  Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes.

Authors:  S Roy; V Dubowitz
Journal:  J Neurol Sci       Date:  1970-07       Impact factor: 3.181

4.  [Shorter autoradiographic exposition of electron microscopic preparations by scintillators].

Authors:  H A Fischer; H Korr; H Thiele; G Werner
Journal:  Naturwissenschaften       Date:  1971-02

5.  Normal mammalian muscle differentiation and gene control of isocitrate dehydrogenase synthesis.

Authors:  B Mintz; W W Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  The importance of serum pyruvate kinase in neuromuscular diseases and carrier states.

Authors:  J Sage; Y Inati; F Samaha
Journal:  Muscle Nerve       Date:  1979 Sep-Oct       Impact factor: 3.217

7.  Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.

Authors:  M Zatz; O Frota-Pessoa; J A Levy; C A Peres
Journal:  J Genet Hum       Date:  1976-06

8.  Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.

Authors:  M E Percy; L S Chang; E G Murphy; I Oss; C Verellen-Dumoulin; M W Thompson
Journal:  Muscle Nerve       Date:  1979 Sep-Oct       Impact factor: 3.217

9.  Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).

Authors:  M Zatz; L J Shapiro; D S Campion; M M Kaback; P A Otto
Journal:  J Neurol Sci       Date:  1980-06       Impact factor: 3.181

10.  Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique.

Authors:  A Moosa; B H Brown; V Dubowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.